The indicators of spermatogenesis and the state of LPO and antioxidant protection in men with pathozoospermia after COVID-19 were assessed before and after treatment an antioxidant complex. Blood plasma served as the material for biochemical studies. In the examined patients, the parameters of spermatogenesis, as well as blood concentration of LPO components (diene conjugates and TBA-reactive substances) were analyzed. The total antioxidant activity of the blood was determined as an indicator characterizing the total activity of LPO inhibitors and determining its buffer capacity. In patients recovered from COVID-19, an increase in spermatogenesis disorders and shifts towards the predominance of prooxidant factors were observed. After a course (1 month) of antioxidant complex, patients showed increased sperm motility, decreased leukocyte count in the ejaculate, and restored balance in the prooxidant—antioxidant system towards antioxidant components. The effectiveness of correction of post-COVID disorders largely depends on the degree of damage to the structure and function of cell membranes caused by oxidative stress. The use of the antioxidant complex is a promising option, because it reduces the level of LPO, enhances antioxidant protection of the body, and also normalizes some parameters of spermatogenesis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abbas AM, Fathy SK, Khamees AA, Salem AS, Ahmed L. A focused review on the genital and sexual affection of COVID-19 patients. J. Gynecol. Obstet. Hum. Reprod. 2020;49(8):101848. doi: https://doi.org/10.1016/j.jogoh.2020.101848
Flaifel A, Guzzetta M, Occidental M, Najari BB, Melamed J, Thomas KM, Deng FM. Testicular changes associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Arch. Pathol. Lab. Med. 2021;145(1):8-9. doi: https://doi.org/10.5858/arpa.2020-0487-LE
Eisenberg ML. Coronavirus disease 2019 and men’s reproductive health. Fertil. Steril. 2020;113(6):1154. doi: https://doi.org/10.1016/j.fertnstert.2020.04.039
Machado B, Barcelos Barra G, Scherzer N, Massey J, Dos Santos Luz H, Henrique Jacomo R, Herinques Santa Rita T, Davis R. Presence of SARS-CoV-2 RNA in semen-cohort study in the United States COVID-19 positive patients. Infect. Dis. Rep. 2021;13(1):96-101. doi: https://doi.org/10.3390/idr13010012
Kurashova NA, Dashiev BG, Kudeyarova EA, Kolesnikova LI. Men’s reproductive health: oxidative stress and the effectiveness of antioxidant therapy. Int. J. Biomed. 2021;11(3):333-336. doi: https://doi.org/10.21103/Article11(3)_RA4
Darenskaya MA, Kolesnikova LI, Kolesnikov SI. COVID-19: oxidative stress and the relevance of antioxidant therapy. Vestn. Ross. Akad. Med. Nauk. 2020;75(4):318-325. Russian. doi: https://doi.org/10.15690/vramn1360
Kurashova NA, Dashiev BG, Kolesnikov SI, Kolesnikova LI. Indicators of the lipid peroxidation-antioxidant protection system as important metabolic markers of reproductive potential in men. Bull. Exp. Biol. Med. 2021;171(6):685-690. doi: https://doi.org/10.1007/s10517-021-05295-0
Darenskaya M, Kolesnikova L, Kolesnikov S. The association of respiratory viruses with oxidative stress and antioxidants. Implications for the COVID-19 pandemic. Curr. Pharm. Des. 2021;27(13):1618-1627. doi: https://doi.org/10.2174/1381612827666210222113351
Comhaire FH, El Garem Y, Mahmoud A, Eertmans F, Schoonjans F. Combined conventional/antioxidant “Astaxanthin” treatment for male infertility: a double blind, randomized trial. Asian J. Androl. 2005;7(3):257-262. doi: https://doi.org/10.1111/j.1745-7262.2005.00047.x
Lu YP, Liu SY, Sun H, Wu XM, Li JJ, Zhu L. Neuroprotective effect of astaxanthin on H(2)O(2)-induced neurotoxicity in vitro and on focal cerebral ischemia in vivo. Brain Res. 2010;1360:40-48. doi: https://doi.org/10.1016/j.brainres.2010.09.016
Wang JY, Lee YJ, Chou MC, Chang R, Chiu CH, Liang YJ, Wu LS. Astaxanthin protects steroidogenesis from hydrogen peroxide-induced oxidative stress in mouse Leydig cells. Mar. Drugs. 2015;13(3):1375-1388. doi: https://doi.org/10.3390/md13031375
Ma L, Xie W, Li D, Shi L, Ye G, Mao Y, Xiong Y, Sun H, Zheng F, Chen Z, Qin J, Lyu J, Zhang Y, Zhang M. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. J. Med. Virol. 2021;93(1):456-462. doi: https://doi.org/10.1002/jmv.26259
Kurashova NA, Dashiev BG, Kolesnikova LI. Glutathione-dependent mechanisms of antioxidant defense in men with pathozoospermia after COVID-19 infection. Int. J. Biomed. 2021;11(4):543-545. doi: https://doi.org/10.21103/Article11(4)_ОА23
Shatylko TV, Gamidov SI, Popova AYu. Evaluating the effect of BESTFertil antioxidant complex on semen parameters and severity of asthenic syndrome in men with a recent history of novel coronavirus infection (COVID-19). Androl. Genit. Khir. 2021;22(4):68-76. Russian. doi: https://doi.org/10.17650/1726-9784-2021-22-4-68-76
Mohammadi Roushandeh A, Salehi I, Mortazavi M. Protective effects of restricted diet and antioxidants on testis tissue in rats fed with high-fat diet. Iran. Biomed. J. 2015;19(2):96-101. doi: https://doi.org/10.6091/ibj.1398.2015
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 173, No. 5, pp. 572-577, May, 2022
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kurashova, N.A., Dashiev, B.G., Kolesnikov, S.I. et al. Changes in Spermatogenesis, Lipoperoxidation Processes, and Antioxidant Protection in Men with Pathozoospermia after COVID-19. The Effectiveness of Correction with a Promising Antioxidant Complex. Bull Exp Biol Med 173, 606–610 (2022). https://doi.org/10.1007/s10517-022-05596-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-022-05596-y